Chemotherapy Combined With Immunotherapy in HER 2 Insertion or Amplification Advanced NSCLC
NCT04324125
·
clinicaltrials.gov ↗
RECRUITING
Status
70
Enrollment
OTHER
Sponsor class
Conditions
Non Small Cell Lung Cancer
Sponsor
Hunan Province Tumor Hospital